[The antiviral activity of deitiforin in experimental para-influenza infection].

Autor: Boldasov VK, Kalinina NA, Revunova OV, Guseva VM, Leonov VM, Sukhinin VP, Il'enko VI
Jazyk: ruština
Zdroj: Voprosy virusologii [Vopr Virusol] 1991 Sep-Oct; Vol. 36 (5), pp. 389-92.
Abstrakt: Deitiforin in HEp-2 cell culture was shown to inhibit replication of the reference PIV-3 strain when administered 1 hour before virus inoculation. The most marked effect of the drug was observed in the first 4 days of observation. In experimental newborn mice infected with parainfluenza virus 3 deitiforin protected the animals from developing the infection. In humans given deitiforin reaction to vaccination was found to develop 5-6 times more rarely than in the control group, PIV-3 could be isolated twice as rarely, and a diagnostically significant rise of specific antibody levels was observed less frequently.
Databáze: MEDLINE